Sun Pharmaceutical Industries share price

Moderate risk
  • 21%Low risk
  • 21%Moderate risk
  • 21%Balanced risk
  • 21%High risk
  • 21%Extreme risk
  • 1,757.70(-0.47%)
    March 26, 2025 15:51:18 PM IST
    • NSE
    • BSE
  • Vol : 1.90M (NSE + BSE)
    Last 20 day avg : 2.23 M

Sun Pharmaceutical Industries is trading -0.47% lower at Rs 1,757.70 as compared to its last closing price. Sun Pharmaceutical Industries has been trading in the price range of 1,770.60 & 1,745.80. Sun Pharmaceutical Industries has given -6.45% in this year & 0.97% in the last 5 days. Sun Pharmaceutical Industries has TTM P/E ratio 39.53 as compared to the sector P/E of 29.60.There are 31 analysts who have initiated coverage on Sun Pharmaceutical Industries. There are 13 analysts who have given it a strong buy rating & 12 analysts have given it a buy rating. 2 analysts have given the stock a sell rating.The company posted a net profit of 2,903.38 Crores in its last quarter.Listed peers of Sun Pharmaceutical Industries include Sun Pharmaceutical Industries (-0.47%), Divis Laboratories (-0.02%), Cipla (-2.32%).The Mutual Fund holding in Sun Pharmaceutical Industries was at 12.24% in 31 Dec 2024. The MF holding has increased from the last quarter. The FII holding in Sun Pharmaceutical Industries was at 18.04% in 31 Dec 2024. The FII holding has increased from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Key Metrics

Updated on Mar 26, 2025, 07:10 PM UTC

  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.88
    Lower than industry
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    6.65
    Higher than historical values
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    36.98
    Higher than historical values
  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    1.00
    Medium volatility
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    0.05
    Higher than industry
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    -
Price range
Day Range
Lowest
1,745.80
Highest
1,770.60
52 week range
Lowest
1,376.75
Highest
1,960.20
Sun Pharmaceutical Industries Financials
Financials
Financials include key reports like the Profit & Loss Statement (P&L), Balance Sheet, and Cash Flow Statement, providing insights into a company's performance, financial health, and liquidity
View all
  • Income
  • Balance Sheet
  • Cash Flow
Loading...
Units in the chart are in crores
Insights
  • Financial
  • Valuation
    • financial-insightsCompany is profitable
    • financial-insightsThe company's revenue grew in December quarter by 10.46% from Rs 13675.46 crore to Rs 12380.70 crore, year-on-year
    • financial-insightsThe company has grown its December quarter profit by 15.04% from Rs 2523.75 crore to Rs 2903.38 crore, year-on-year
    • financial-insightsThe debt to equity of the company is higher than the industry median
    • financial-insightsCompany can comfortably pay off its interest obligations with its earnings
Sun Pharmaceutical Industries Technical Analysis
Pivot Level - classic
Info
Key price levels (support and resistance) calculated using the previous day's high, low, and close, aiding in technical analysis and trading decisions
  • R1
  • 1,756.50
  • R2
  • 1,919.10
  • R3
  • 2,019.85
Pivot1,655.75
  • S1
  • 1,493.15
  • S2
  • 1,392.40
  • S3
  • 1,229.80
Short Term
Info
Considers price movement over the last 1-2 weeks
Not Available
Long Term
Info
Considers price movement over the last 6 months
Not Available
  • Very Bearish
  • Bearish
  • Neutral
  • Very Bullish
  • Bullish
Trends unavailable at the moment.
Sun Pharmaceutical Industries Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Sun Pharmaceutical Industries
Bullish
1,757.70-0.474,21,720.8142.766.730.870.48
Divis Laboratories
Bullish
5,839.20-0.021,55,012.4197.8911.560.510.01
Cipla
Bearish
1,476.20-2.321,19,219.9828.354.610.850.84
Torrent Pharmaceuticals
Bullish
3,230.95-0.041,09,345.1269.0616.150.9824.33
Dr Reddys Laboratories
Neutral
1,163.85-1.4197,112.2418.313.570.662.12
Sun Pharmaceutical Industries Shareholding
View All
Shareholding Pattern
Breakdown of a company's ownership structure, showing stakes held by Promoters, Mutual Funds, FII(s) & Others.
    No Data
    Shareholding pattern for Sun Pharmaceutical Industries is currently unavailable
    Please check back later.
    Shareholding Insights
    • InsightsPledged found - Promoter(s) have pledged 0.69% of shares.
    • InsightsPromoter(s) have decreased pledged shares to 0.79% from 0.69% earlier.
    • InsightsPromoter(s) holds a high stake in the company at 54.48%
    • InsightsFIIs are invested in this company
    • InsightsFIIs holding has increased by 0.03 percentage points from previous quarter
    • InsightsMutual Funds holding has increased by 0.13 percentage points from previous quarter
    Mutual Fund Ownership
    View all
    LIC MF Healthcare Fund Regular Growth
    NA
    • Amount Invested (Cr.) 7.62
    • % of AUM 9.93
    ICICI Prudential ESG Exclusionary Strategy Fund Regular Growth
    4/5
    • Amount Invested (Cr.) 108.52
    • % of AUM 8.01
    SBI Equity Minimum Variance Fund Regular Growth
    NA
    • Amount Invested (Cr.) 14.92
    • % of AUM 7.54
    ICICI Prudential Dividend Yield Equity Fund Growth
    NA
    • Amount Invested (Cr.) 296.99
    • % of AUM 6.49
    Shriram Multi Sector Rotation Fund Regular Growth
    NA
    • Amount Invested (Cr.) 11.01
    • % of AUM 6.29
    Sun Pharmaceutical Industries Corporate Actions
    View all
    • Board Meetings
    • AGM
    • Dividends
    • Bonus
    • Split
    • Rights
    Meeting DatePurpose
    2025-01-31Quarterly Results & Interim Dividend
    2024-10-28Quarterly Results
    2024-08-01Quarterly Results
    2024-05-22Audited Results & Final Dividend
    2024-01-31Quarterly Results & Interim Dividend
    About the company Sun Pharmaceutical Industries
    • IndustryBiotechnology & Drugs
    • ISININE044A01036
    • BSE Code524715
    • NSE CodeSUNPHARMA
    Sun Pharmaceutical Industries Limited is an India-based specialty generic pharmaceutical company with a presence in specialty, generics and consumer healthcare products. It is engaged in manufacturing, developing, and marketing a range of branded and generic formulations and active pharmaceutical ingredients (APIs). It produces a diverse and complementary portfolio of generic and specialty medicines targeting a wide spectrum of chronic and acute treatments. It offers a variety of dosage forms, including orals, creams, ointments, injectables, sprays, and liquids. Its global specialty portfolio spans advanced products in dermatology, ophthalmology, and onco-dermatology. Its marketed specialty portfolio includes Ilumya/ Ilumetri, Winlevi, Levulan Kerastick + BLU-U, Absorica LD, Odomzo, Cequa, Bromsite, Xelpros, and others. Its vertically integrated operations deliver medicines to physicians and consumers in over 100 countries. Its manufacturing facilities are spread across six continents.
    • Management Info
    • Dilip ShanghviChairman, Managing Director, Executive Director
    • C. S. MuralidharanChief Financial Officer
    • Aalok ShanghviWhole-time Director, Executive Vice-President, Emerging Markets, Global generic R&D, Global BD (Generics Segment) & API
    • Anoop DeshpandeCompliance Officer, Company Secretary
    Sun Pharmaceutical Industries Share Price FAQs

    Sun Pharmaceutical Industries is trading at 1757.70 as on Wed Mar 26 2025 10:21:18. This is -0.47% lower as compared to its previous closing price of 1766.00.

    The market capitalization of Sun Pharmaceutical Industries is 421720.81 Cr as on Wed Mar 26 2025 10:21:18.

    The average broker rating on Sun Pharmaceutical Industries is Buy. The breakup of analyst rating is given below -

    • 13 analysts have given a strong buy rating
    • 12 analysts have given a buy rating
    • 4 analysts have given a hold rating
    • 2 analysts have given a sell rating
    • 0.00 analysts have given a strong sell rating

    The 52 wk high for Sun Pharmaceutical Industries is 1960.20 whereas the 52 wk low is 1376.75

    Sun Pharmaceutical Industries can be analyzed on the following key metrics -

    • TTM P/E: 39.53
    • Sector P/E: 29.60
    • Dividend Yield: 0.88%
    • D/E ratio: -

    Sun Pharmaceutical Industries reported a net profit of 9576.38 Cr in 2024.

    The Mutual Fund Shareholding was 12.24% at the end of 31 Dec 2024.